Allied Corp banner
A

Allied Corp
OTC:ALID

Watchlist Manager
Allied Corp
OTC:ALID
Watchlist
Price: 0.0005 USD Market Closed
Market Cap: $115.5

Allied Corp
Stock-Based Compensation

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Allied Corp
Stock-Based Compensation Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Stock-Based Compensation CAGR 3Y CAGR 5Y CAGR 10Y
A
Allied Corp
OTC:ALID
Stock-Based Compensation
$410.9k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bausch Health Companies Inc
TSX:BHC
Stock-Based Compensation
$216m
CAGR 3-Years
20%
CAGR 5-Years
16%
CAGR 10-Years
4%
Canopy Growth Corp
TSX:WEED
Stock-Based Compensation
CA$2.8m
CAGR 3-Years
-56%
CAGR 5-Years
-51%
CAGR 10-Years
3%
Cronos Group Inc
TSX:CRON
Stock-Based Compensation
$7.1m
CAGR 3-Years
-22%
CAGR 5-Years
-14%
CAGR 10-Years
N/A
Mind Medicine (MindMed) Inc
NASDAQ:MNMD
Stock-Based Compensation
$17.9m
CAGR 3-Years
2%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
K
Knight Therapeutics Inc
TSX:GUD
Stock-Based Compensation
CA$8.1m
CAGR 3-Years
63%
CAGR 5-Years
33%
CAGR 10-Years
6%
No Stocks Found

Allied Corp
Glance View

Market Cap
115.5 USD
Industry
Pharmaceuticals

Allied Corp. operates as a medical cannabis company. The company is headquartered in Kelowna, British Columbia. The company went IPO on 2018-12-04. The firm is focused on creating and providing health solutions to address medical mental health issues. The firm focuses to discover medical technologies, which are cannabis derived to target full scope therapy and support for trauma survivors, military veterans and first responders. Its functional mushroom formulation targets major depression and anxiety. The firm is also engaged in research and development activities in the psilocybin space and holds formulations.

ALID Intrinsic Value
Not Available

See Also

What is Allied Corp's Stock-Based Compensation?
Stock-Based Compensation
410.9k USD

Based on the financial report for Nov 30, 2024, Allied Corp's Stock-Based Compensation amounts to 410.9k USD.

What is Allied Corp's Stock-Based Compensation growth rate?
Stock-Based Compensation CAGR 1Y
-84%

Over the last year, the Stock-Based Compensation growth was -84%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett